secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001193125-22-005070
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa presents at J.P. Morgan Healthcare Conference; no specific details disclosed in filing
--------------------------------------------------------------------------------

- Company delivered revised corporate presentation at 40th Annual J.P. Morgan Healthcare Conference on Jan 10, 2022.
- Filing includes presentation slides, but only title page and partial sentence provided; no substantive data available.
- No financial results, pipeline updates, or guidance changes disclosed in the 8-K or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000119312522005070/0001193125-22-005070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000119312522005070/d143088d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-005070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer